They may be acquired, as in tumor-induced osteomalacia due to tumors secreting FGF23, or due to genetic mutations associated with loss-of-function of PHEX, DMP1 and ENPP1, and gain-of-function of FGF23 [6–8]. This evidence concerns the gene FGF23 and osteomalacia.